STAT
FEBRUARY 14, 2025
Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. The oversight body noted the communications had not been subject to the regulatory approval process. A member of the U.K.
Pharma Marketing Network
APRIL 25, 2025
Introduction In todays complex healthcare environment, what does it truly mean to practice Integrated Marketing Communications in pharma? This article explores how Integrated Marketing Communications (IMC) drives brand cohesion, regulatory clarity, and market growth within the pharmaceutical industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 11, 2024
Food and Drug Administration has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena Williams, the third time this year the agency has taken a major pharmaceutical company to task for its marketing. The agency is upset with Abbvie for a couple of reasons.
pharmaphorum
MARCH 23, 2022
Whether you’re a large pharma company or a small, emerging one, communication is key. Success or failure hinges on communicating the advantages of your offerings to both prescribing providers and patients. This webinar will also explore: What’s next for digital healthcare communications. About the panel.
pharmaphorum
MAY 10, 2022
Engaging, strategic, customer-centric communication is important in any industry, and no industry has been unaffected by the changing world of digital communication. Fundamentally, the aims of healthcare communication haven’t changed, panellists said. And I think that’s changing a lot the way that we do communication.”.
pharmaphorum
MAY 13, 2021
Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. The post 4 ways to embed data-driven best practice in pharma HCP communications appeared first on. For more information, visit veeva.com/eu.
Drug Patent Watch
DECEMBER 10, 2024
The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48 As a result, many companies are turning to integrated CDMOs to simplify their outsourcing processes and improve efficiency. billion in 2022 and is expected to grow at a compound annual growth rate of 5.3%
Expert insights. Personalized for you.
293 
Let's personalize your content